61 related articles for article (PubMed ID: 11234143)
1. [Virus-specific antibodies and interferon therapy in chronic hepatitis C].
Loginov AS; Tsaregorodtseva TM; Zotina MM; Serova TI; Iakimchuk GN
Ter Arkh; 2001; 73(1):52-4. PubMed ID: 11234143
[TBL] [Abstract][Full Text] [Related]
2. Changes in hepatitis C virus (HCV) antibody status in patients with chronic hepatitis C after eradication of HCV infection by interferon therapy.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kuzuya T; Honda T; Hayashi K; Nakano I; Katano Y; Goto H
Clin Infect Dis; 2005 Mar; 40(6):e49-54. PubMed ID: 15736006
[TBL] [Abstract][Full Text] [Related]
3. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
4. HCV-RNA and anti-HCV IgM in Egyptian subjects bearing IgG anti-HCV antibodies.
el-Gohary A; Hosny AM; Fawaz N; Heiba A; Abdalla E; Kawano F; Kiyokawa T
Jpn J Infect Dis; 1999 Jun; 52(3):113-6. PubMed ID: 10507990
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of specific humoral response to hepatitis C core antigen in children].
Kupś J; Woźniakowska-Gesicka T
Przegl Lek; 2003; 60(12):802-5. PubMed ID: 15058020
[TBL] [Abstract][Full Text] [Related]
6. Low-level hepatitis C viremia and humoral immune response to NS4 in chronic hepatitis B virus-hepatitis C virus coinfection.
Chu CM; Sheen IS; Liaw YF
Scand J Gastroenterol; 2004 Aug; 39(8):778-82. PubMed ID: 15513365
[TBL] [Abstract][Full Text] [Related]
7. IgE antibodies to hepatitis C virus core and nonstructural antigens in chronic hepatitis C patients before and after antiviral treatment.
Silva JPCG; Jesus LS; Isabel Schinoni M; Oliveira IS; Atta MLBS; Atta AM
Int Immunopharmacol; 2021 Apr; 93():107405. PubMed ID: 33529909
[TBL] [Abstract][Full Text] [Related]
8. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
9. [Studies on the correlation between titer of antibodies against different function regions of hepatitis C virus and HCV RNA of chronic patients].
Zhang HQ; Wang GH; Chen K; Xiu BS; Song XG; Liu HZ; Ling SG
Zhonghua Gan Zang Bing Za Zhi; 2003 Dec; 11(12):754-5. PubMed ID: 14697143
[TBL] [Abstract][Full Text] [Related]
10. Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection.
Hsu TC; Chen TY; Lin MC; Tzang BS; Tsay GJ
J Gastroenterol Hepatol; 2005 May; 20(5):733-8. PubMed ID: 15853987
[TBL] [Abstract][Full Text] [Related]
11. [Antibodies to different virus antigens in patients with chronic hepatitis C].
Krasavtsev EL; Zhavoronok SV; Mitsura VM; Demchilo AP
Zh Mikrobiol Epidemiol Immunobiol; 2006; (2):57-61. PubMed ID: 16758901
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of HCV related acute hepatitis by serial determination of IgM to HCV: a preliminary observation.
Sagnelli E; Coppola N; Marrocco C; Coviello G; Rossi G; Battaglia M; Sagnelli C; Messina V; Tonziello A; Scolastico C; Filippini P
J Biol Regul Homeost Agents; 2003; 17(2):207-10. PubMed ID: 14518726
[TBL] [Abstract][Full Text] [Related]
13. Direct evidence for immunomodulatory properties of ribavirin on T-cell reactivity to hepatitis C virus.
Rigopoulou EI; Abbott WG; Williams R; Naoumov NV
Antiviral Res; 2007 Jul; 75(1):36-42. PubMed ID: 17210188
[TBL] [Abstract][Full Text] [Related]
14. Antigenic relevance of F protein in chronic hepatitis C virus infection.
Komurian-Pradel F; Rajoharison A; Berland JL; Khouri V; Perret M; Van Roosmalen M; Pol S; Negro F; Paranhos-Baccalà G
Hepatology; 2004 Oct; 40(4):900-9. PubMed ID: 15382175
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of anti-hepatitis C virus antibody-secreting B cells in patients with chronic hepatitis C.
Umemura T; Wang RY; Schechterly C; Shih JW; Kiyosawa K; Alter HJ
Hepatology; 2006 Jan; 43(1):91-9. PubMed ID: 16323211
[TBL] [Abstract][Full Text] [Related]
16. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
[TBL] [Abstract][Full Text] [Related]
17. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
[TBL] [Abstract][Full Text] [Related]
18. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.
Januszkiewicz-Lewandowska D; Wysocki J; Pernak M; Nowicka K; Zawada M; Rembowska J; Lewandowski K; Mańkowski P; Nowak J
Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422
[TBL] [Abstract][Full Text] [Related]
19. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
20. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
